Keywords: novartis, compares, growth, hormone, therapies, says, levels

Novartis Compares Growth Hormone Therapies

Article | 17 June 1999

- Novartis says that levels of growth hormone and insulin-like growthfactor-1 were significantly decreased in 125 acromegaly patients treated with its once-monthly ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Novartis

Ipsen

Go to company listing

Related Drugs

Humulin 70-30

Insulin

Humulin N

Humulin R

Octreotide Acetate

Go to drug listing